We advised AIMM Therapeutics, an Amsterdam based biotech company, in relation to its most recent financing round. AIMM Therapeutics develops antibody-based treatments by discovering the most effective antibodies against cancer and infectious diseases that are obtained from individuals who have overcome disease or from immunized animals.